Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.
2.

Donepezil for dementia due to Alzheimer's disease.

Birks JS, Harvey R.

Cochrane Database Syst Rev. 2003;(3):CD001190. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD001190.

PMID:
12917900
3.

Donepezil for dementia due to Alzheimer's disease.

Birks J, Harvey RJ.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001190. Review.

PMID:
16437430
4.

Perspectives in the management of Alzheimer's disease: clinical profile of donepezil.

Rogers SL.

Dement Geriatr Cogn Disord. 1998;9 Suppl 3:29-42. Review.

PMID:
9853200
5.

Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness.

Wolfson C, Oremus M, Shukla V, Momoli F, Demers L, Perrault A, Moride Y.

Clin Ther. 2002 Jun;24(6):862-86; discussion 837. Review.

PMID:
12117079
6.

The pharmacology of donepezil: a new treatment of Alzheimer's disease.

Wilkinson DG.

Expert Opin Pharmacother. 1999 Nov;1(1):121-35. Review.

PMID:
11249555
7.

Donepezil.

Bryson HM, Benfield P.

Drugs Aging. 1997 Mar;10(3):234-9; discussion 240-1. Review.

PMID:
9108896
8.

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.

Whitehead A, Perdomo C, Pratt RD, Birks J, Wilcock GK, Evans JG.

Int J Geriatr Psychiatry. 2004 Jul;19(7):624-33. Review.

PMID:
15254918
9.

Donepezil: in vascular dementia.

Goldsmith DR, Scott LJ.

Drugs Aging. 2003;20(15):1127-36. Review.

PMID:
14651435
10.

Reviewing the role of donepezil in the treatment of Alzheimer's disease.

Doody RS, Cummings JL, Farlow MR.

Curr Alzheimer Res. 2012 Sep;9(7):773-81. Review.

PMID:
22175653
11.

Alzheimer's disease: the benefits of early treatment.

Gauthier SG.

Eur J Neurol. 2005 Oct;12 Suppl 3:11-6. Review.

PMID:
16144532
12.

Atypical aging in Down syndrome.

Zigman WB.

Dev Disabil Res Rev. 2013;18(1):51-67. doi: 10.1002/ddrr.1128. Review.

PMID:
23949829
13.

Does the evidence say a 4-point change in ADAS-cog score is clinically significant?

Oremus M.

Alzheimers Dement. 2014 May;10(3):416-7. doi: 10.1016/j.jalz.2013.12.017. Epub 2014 Mar 12. Review. No abstract available.

PMID:
24630567
Items per page

Supplemental Content

Write to the Help Desk